top of page
Search

HIV B-VAC project funded by ANRS

  • ART-TG
  • Sep 29, 2020
  • 1 min read

Updated: May 10, 2021


ART-TG and VRI teams have received 3-year funding from ANRS to develop new HIV vaccines based on CRISPR genome editing of B cells.


 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page